Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1.25%
1,110.47
+13.75
+1.25%
—1,096.721,098.741,113.821,098.74——
SIXC
Communications
SIXC
Communications
SIXC
-1.19%
604.07
-7.25
-1.19%
—611.32611.32611.32603.33——
SIXE
Energy
SIXE
Energy
SIXE
+2.56%
1,201.49
+29.95
+2.56%
—1,171.541,176.151,202.381,176.15——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.01%
1,765.30
+17.67
+1.01%
—1,747.631,747.671,770.511,744.43——
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
630.42
-1.07
-0.17%
—631.49631.23633.90627.95——
SIXR
Staples
SIXR
Staples
SIXR
-1.00%
841.45
-8.49
-1.00%
—849.94850.23850.23836.20——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.35%
218.83
+0.77
+0.35%
—218.06218.06219.96218.02——
SIXT
Technology
SIXT
Technology
SIXT
+1.31%
3,582.23
+46.20
+1.31%
—3,536.033,549.423,590.523,543.38——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.97%
913.89
+8.82
+0.97%
—905.07908.07916.83907.68——
SIXV
Health care
SIXV
Health care
SIXV
-0.38%
1,444.33
-5.53
-0.38%
—1,449.861,451.341,464.451,440.75——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,412.96
-17.51
-0.72%
—2,430.472,415.842,422.952,396.14——
FME:ETR
Fresenius Medical Care AG
€37.60
+0.89%
(+0.33) 1D
May 12, 2:20:24 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for FME...
Open
€37.10
High
€38.44
Low
€37.10
Mkt. cap
11.03B
Avg. vol.
815.12K
Volume
189.01K
Dividend
3.96%
Quarterly dividend
€0.37
Ex dividend date
May 22, 2026
P/E ratio
11.46
52-wk high
€54.02
52-wk low
€34.57
EPS
€3.28
Shares outstanding
293.41M
No. of employees
108K
News stories
From sources across the web
Profile
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives. With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan. The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue. As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
About Fresenius Medical Care AG
CEOHelen Giza
Employees108K
Founded1996
Headquarters-
SectorHealth care provider
Websitefreseniusmedicalcare.com
Last report
May 5, 2026
Fiscal Period
Q1 2026
EPS / Est. (EUR)
€0.91 / €1.05
-12.94%miss
Revenue / Est. (EUR)
4.61B / 4.62B
-0.07%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.79B
4.88B
5.07B
4.61B
Cost of goods sold
3.58B
3.64B
3.68B
3.43B
Cost of revenue
3.58B
3.64B
3.68B
3.43B
Research and development expenses
38.12M
37.75M
38.63M
38.31M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
791.98M
705.44M
784.62M
748.94M
Operating expense
819.96M
740.50M
796.34M
803.94M
Total operating expenses
4.40B
4.38B
4.48B
4.24B
Operating income
394.40M
501.72M
592.03M
375.56M
Other non operating income
-
-
-
-
EBT including unusual items
350.55M
402.57M
508.46M
207.52M
EBT excluding unusual items
346.60M
462.70M
541.79M
334.44M
Income tax expense
78.26M
75.22M
106.44M
42.75M
Effective tax rate
22.32%
18.69%
20.93%
20.60%
Other operating expenses
-10.14M
-2.69M
-26.91M
16.69M
Net income
225.27M
274.80M
327.08M
117.53M
Net profit margin
4.70%
5.63%
6.45%
2.55%
Earnings per share
0.91
1.10
1.44
0.91
Interest and investment income
21.85M
19.16M
13.62M
14.62M
Interest expense
-96.58M
-93.10M
-99.02M
-93.30M
Net interest expenses
-74.73M
-73.94M
-85.40M
-78.68M
Depreciation and amortization charges
-
-
-
-
EBITDA
743.68M
853.56M
780.17M
727.79M
Gain or loss from assets sale
-8.00M
50.35M
17.92M
8.77M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer